Literature DB >> 33979585

MDSC: Markers, development, states, and unaddressed complexity.

Samarth Hegde1, Andrew M Leader1, Miriam Merad2.   

Abstract

Myeloid-derived suppressor cells (MDSCs) are one of the most discussed biological entities in immunology. While the context and classification of this group of cells has evolved, MDSCs most commonly describe cells arising during chronic inflammation, especially late-stage cancers, and are defined by their T cell immunosuppressive functions. This MDSC concept has helped explain myeloid phenomena associated with disease outcome, but currently lacks clear definitions and a unifying framework across pathologies. Here, we propose such a framework to classify MDSCs as discrete cell states based on activation signals in myeloid populations leading to suppressive modes characterized by specific, measurable effects. Developing this level of knowledge of myeloid states across pathological conditions may ultimately transform how disparate diseases are grouped and treated.
Copyright © 2021. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33979585      PMCID: PMC8709560          DOI: 10.1016/j.immuni.2021.04.004

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  110 in total

1.  Systemic bacillus Calmette-Guérin (BCG) activates natural suppressor cells.

Authors:  J A Bennett; V S Rao; M S Mitchell
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

2.  Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host.

Authors:  Bo Huang; Ping-Ying Pan; Qingsheng Li; Alice I Sato; David E Levy; Jonathan Bromberg; Celia M Divino; Shu-Hsia Chen
Journal:  Cancer Res       Date:  2006-01-15       Impact factor: 12.701

3.  The Unfolded Protein Response Mediator PERK Governs Myeloid Cell-Driven Immunosuppression in Tumors through Inhibition of STING Signaling.

Authors:  Eslam Mohamed; Rosa A Sierra; Jimena Trillo-Tinoco; Yu Cao; Patrick Innamarato; Kyle K Payne; Alvaro de Mingo Pulido; Jessica Mandula; Shuzhong Zhang; Paul Thevenot; Subir Biswas; Sarah K Abdalla; Tara Lee Costich; Kay Hänggi; Carmen M Anadon; Elsa R Flores; Eric B Haura; Shikhar Mehrotra; Shari Pilon-Thomas; Brian Ruffell; David H Munn; Juan R Cubillos-Ruiz; Jose R Conejo-Garcia; Paulo C Rodriguez
Journal:  Immunity       Date:  2020-04-14       Impact factor: 31.745

4.  Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kappaB.

Authors:  Chiara Porta; Monica Rimoldi; Geert Raes; Lea Brys; Pietro Ghezzi; Diana Di Liberto; Francesco Dieli; Serena Ghisletti; Gioacchino Natoli; Patrick De Baetselier; Alberto Mantovani; Antonio Sica
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-17       Impact factor: 11.205

5.  Development and function of myeloid-derived suppressor cells generated from mouse embryonic and hematopoietic stem cells.

Authors:  Zuping Zhou; Deborah L French; Ge Ma; Samuel Eisenstein; Ying Chen; Celia M Divino; Gordon Keller; Shu-Hsia Chen; Ping-Ying Pan
Journal:  Stem Cells       Date:  2010-03-31       Impact factor: 6.277

6.  Regenerative lineages and immune-mediated pruning in lung cancer metastasis.

Authors:  Ashley M Laughney; Jing Hu; Nathaniel R Campbell; Samuel F Bakhoum; Manu Setty; Vincent-Philippe Lavallée; Yubin Xie; Ignas Masilionis; Ambrose J Carr; Sanjay Kottapalli; Viola Allaj; Marissa Mattar; Natasha Rekhtman; Joao B Xavier; Linas Mazutis; John T Poirier; Charles M Rudin; Dana Pe'er; Joan Massagué
Journal:  Nat Med       Date:  2020-02-10       Impact factor: 53.440

7.  Epigenetic therapy inhibits metastases by disrupting premetastatic niches.

Authors:  Zhihao Lu; Jianling Zou; Shuang Li; Michael J Topper; Yong Tao; Hao Zhang; Xi Jiao; Wenbing Xie; Xiangqian Kong; Michelle Vaz; Huili Li; Yi Cai; Limin Xia; Peng Huang; Kristen Rodgers; Beverly Lee; Joanne B Riemer; Chi-Ping Day; Ray-Whay Chiu Yen; Ying Cui; Yujiao Wang; Yanni Wang; Weiqiang Zhang; Hariharan Easwaran; Alicia Hulbert; KiBem Kim; Rosalyn A Juergens; Stephen C Yang; Richard J Battafarano; Errol L Bush; Stephen R Broderick; Stephen M Cattaneo; Julie R Brahmer; Charles M Rudin; John Wrangle; Yuping Mei; Young J Kim; Bin Zhang; Ken Kang-Hsin Wang; Patrick M Forde; Joseph B Margolick; Barry D Nelkin; Cynthia A Zahnow; Drew M Pardoll; Franck Housseau; Stephen B Baylin; Lin Shen; Malcolm V Brock
Journal:  Nature       Date:  2020-02-26       Impact factor: 69.504

Review 8.  Impact of Retinoic Acid on Immune Cells and Inflammatory Diseases.

Authors:  Luana de Mendonça Oliveira; Franciane Mouradian Emidio Teixeira; Maria Notomi Sato
Journal:  Mediators Inflamm       Date:  2018-08-09       Impact factor: 4.711

9.  Defining the emergence of myeloid-derived suppressor cells in breast cancer using single-cell transcriptomics.

Authors:  Hamad Alshetaiwi; Nicholas Pervolarakis; Laura Lynn McIntyre; Dennis Ma; Quy Nguyen; Jan Akara Rath; Kevin Nee; Grace Hernandez; Katrina Evans; Leona Torosian; Anushka Silva; Craig Walsh; Kai Kessenbrock
Journal:  Sci Immunol       Date:  2020-02-21

Review 10.  Myeloid derived suppressor cells - a new therapeutic target in the treatment of cancer.

Authors:  Robert Wesolowski; Joseph Markowitz; William E Carson
Journal:  J Immunother Cancer       Date:  2013-07-15       Impact factor: 13.751

View more
  53 in total

Review 1.  Cancer vaccines: Building a bridge over troubled waters.

Authors:  MacLean C Sellars; Catherine J Wu; Edward F Fritsch
Journal:  Cell       Date:  2022-07-13       Impact factor: 66.850

Review 2.  Biology of lung macrophages in health and disease.

Authors:  Helena Aegerter; Bart N Lambrecht; Claudia V Jakubzick
Journal:  Immunity       Date:  2022-09-13       Impact factor: 43.474

Review 3.  VEGF/VEGFR-Targeted Therapy and Immunotherapy in Non-small Cell Lung Cancer: Targeting the Tumor Microenvironment.

Authors:  Yueshui Zhao; Sipeng Guo; Jian Deng; Jing Shen; Fukuan Du; Xu Wu; Yu Chen; Mingxing Li; Meijuan Chen; Xiaobing Li; Wanping Li; Li Gu; Yuhong Sun; Qinglian Wen; Jing Li; Zhangang Xiao
Journal:  Int J Biol Sci       Date:  2022-05-29       Impact factor: 10.750

Review 4.  Myeloid-Derived Suppressor Cells: The Expanding World of Helminth Modulation of the Immune System.

Authors:  Mary M Stevenson; Rajesh M Valanparambil; Mifong Tam
Journal:  Front Immunol       Date:  2022-06-10       Impact factor: 8.786

5.  Novel Hypoxia-Associated Gene Signature Depicts Tumor Immune Microenvironment and Predicts Prognosis of Colon Cancer Patients.

Authors:  Yixin Xu; Can Cao; Ziyan Zhu; Yibo Wang; Yulin Tan; Xuezhong Xu
Journal:  Front Genet       Date:  2022-06-06       Impact factor: 4.772

6.  Targeting Inhibition of Accumulation and Function of Myeloid-Derived Suppressor Cells by Artemisinin via PI3K/AKT, mTOR, and MAPK Pathways Enhances Anti-PD-L1 Immunotherapy in Melanoma and Liver Tumors.

Authors:  Mengqi Zhang; Lulu Wang; Wan Liu; Tian Wang; Francesco De Sanctis; Lifang Zhu; Guizhong Zhang; Jian Cheng; Qin Cao; Jingying Zhou; Aldo Tagliabue; Vincenzo Bronte; Dehong Yan; Xianchun Wan; Guang Yu
Journal:  J Immunol Res       Date:  2022-06-22       Impact factor: 4.493

Review 7.  Myeloid-Derived Suppressor Cells as Key Players and Promising Therapy Targets in Prostate Cancer.

Authors:  Izabela Siemińska; Jarek Baran
Journal:  Front Oncol       Date:  2022-07-04       Impact factor: 5.738

8.  Mesenchymal stem cell transplantation alleviated atherosclerosis in systemic lupus erythematosus through reducing MDSCs.

Authors:  Genhong Yao; Jingjing Qi; Xiaojing Li; Xiaojun Tang; Wenchao Li; Weiwei Chen; Nan Xia; Shiying Wang; Lingyun Sun
Journal:  Stem Cell Res Ther       Date:  2022-07-18       Impact factor: 8.079

9.  Multimodal Intralesional Therapy for Reshaping the Myeloid Compartment of Tumors Resistant to Anti-PD-L1 Therapy via IRF8 Expression.

Authors:  Ankit Patel; Takaaki Oba; Ryutaro Kajihara; Toshihiro Yokoi; Scott I Abrams; Fumito Ito
Journal:  J Immunol       Date:  2021-08-06       Impact factor: 5.426

10.  Myeloid-Derived Suppressor Cells Dampen Airway Inflammation Through Prostaglandin E2 Receptor 4.

Authors:  Chiel van Geffen; Astrid Deißler; Sandra Beer-Hammer; Bernd Nürnberg; Rupert Handgretinger; Harald Renz; Dominik Hartl; Saeed Kolahian
Journal:  Front Immunol       Date:  2021-07-12       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.